Effectiveness of Stimulation on the Sciatic Nerve in ACLR

May 4, 2026 updated by: Javier Reina Abellan; PhD, Universidad de Murcia

"Effectiveness of Percutaneous Electrical Nerve Stimulation on the Sciatic Nerve in Patients Undergoing Surgical Reconstruction of the Anterior Cruciate Ligament. A Randomized Clinical Trial".

After randomization, the control group will receive conventional physiotherapy, including manual therapy and therapeutic exercise for ACL rehabilitation. The first experimental group will undergo percutaneous electrical nerve stimulation of the sciatic nerve, while the second experimental group will receive a placebo stimulation. Both interventions aim to improve isometric strength, muscle activation, joint range of motion, and thigh circumference, as well as reduce pain and intra-articular effusion. The procedure involves needle insertion into the sciatic nerve epineurium, placement of a surface electrode on the hamstrings, and connection to an electrostimulator.

Study Overview

Detailed Description

After randomization, participants in the control group will undergo only the conventional physiotherapy program, which consists of manual therapy and therapeutic exercise for the rehabilitation of the anterior cruciate ligament. The first experimental group will receive a percutaneous electrical nerve stimulation protocol applied to the sciatic nerve, consisting of 10 cycles of 10 seconds of electrical current followed by 10 seconds of rest, with the intensity adjusted to the patient's tolerance threshold. The second experimental group will follow the same procedure but with a placebo stimulation. The interventions aim to improve isometric strength, muscle activation, joint range of motion, and thigh circumference, while also reducing pain and intra-articular effusion. The experimental procedure involves inserting a needle into the epineurium of the sciatic nerve after disinfecting the area and placing a surface electrode on the hamstring muscles, followed by connecting the needle to an electrostimulator.

Study Type

Interventional

Enrollment (Estimated)

62

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Madrid
      • Madrid, Madrid, Spain, 28049
        • Recruiting
        • Clinica CEMTRO, Montecarmelo, Madrid
        • Contact:
        • Contact:
          • Javier Reina Abellán, PhD
          • Phone Number: +34 656887703
          • Email: jreina@ucam.edu
        • Principal Investigator:
          • Adrián Cases Sebastià, Physiotherapist
        • Sub-Investigator:
          • Luis Blanco López, Physiotherapist
        • Sub-Investigator:
          • Javier Reina Abellán, PhD
        • Sub-Investigator:
          • Pedro Guillén García, PhD
        • Sub-Investigator:
          • Iván Nacher Moltó, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Use of the Semitendinous and Gracilis tendons for ACL Reconstruction
  • Joint Range of Motion greater than or equal to 90
  • Primary ACL injury in the leg to be treated

Exclusion Criteria:

  • Chronic or rheumatic joint disease
  • Central nervous system disorder
  • Heart disease (pacemaker)
  • Neoplasms
  • Epilepsy
  • Coagulopathies (use of anticoagulants)
  • History of spinal surgery or lumbar disease
  • History of neurological disorders
  • Prosthesis or osteosynthesis in the operated leg
  • Structural discrepancy in lower-limb length
  • Belonephobia (overwhelming fear of needles)
  • Neuropathic pain or bilateral symptoms
  • Use of analgesics
  • Quadriceps tendon graft harvest
  • Body mass index <20 or >30 kg/m²
  • Acute muscle injuries
  • Knee joint instability
  • Acute joint inflammation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group
Percutaneous Electrical Nerve Stimulation on the Sciatic Nerve
No Intervention: Control Group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximal Isometric Strength of the Hamstring Musculature
Time Frame: 5 weeks after surgery

Maximal Isometric Strength of the Hamstring Musculature

This was recorded with the patient in a prone position, with the knee flexed at 90 degrees and the ankle in plantar flexion.

The patient was instructed to perform an isometric knee flexion against a Lafayette hand-held dynamometer, positioned at the level of the Achilles tendon.

Three repetitions were recorded and measured in Newtons, with a 60-second rest interval between repetitions.

5 weeks after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Surface Electromyography of the Hamstring Musculature
Time Frame: 5 weeks after surgery

This variable was assessed in three different positions. The first position involved the patient lying prone with the knee flexed at 90 degrees and the ankle in plantar flexion.

In the second position, the patient was seated at the edge of the examination table with the trunk upright, the hip flexed at 90 degrees, and the knee flexed at 90 degrees, with the ankle in plantar flexion.

In the third position, the patient stood in front of the examination table with the injured leg supported on it. The leg was positioned with 90 degrees of hip flexion, 30 degrees of knee flexion, and the ankle in dorsiflexion.

The percentage of activation of the biceps femoris and semitendinosus muscles was recorded, as well as the mean activation ratio of these muscles and the peak activation of both. The latter two variables were measured in microvolts.

Three repetitions of 5 seconds of activation were performed, with a 60-second rest interval between each repetition.

5 weeks after surgery
Postsurgery Pain
Time Frame: 5 weeks after surgery
NRS scale: 0 = no pain and 10 = the worst pain
5 weeks after surgery
Thigh Circumference Measurement
Time Frame: 5 weeks after surgery

Thigh circumference was measured using a measuring tape, a validated tool with high inter- and intra-rater reliability in patients with anterior cruciate ligament (ACL) reconstruction.

The patient was positioned in a seated posture with the legs hanging off the examination table. The evaluator stood on the ipsilateral side of the operated limb to ensure unobstructed access.

The operated knee was maintained in maximal extension, and the patient was instructed to remain relaxed and avoid any contraction of the thigh musculature that could bias the measurement.

The evaluator then used the measuring tape to encircle the thigh at a point 10 cm above the superior pole of the patella and recorded the circumference.

5 weeks after surgery
Intra-Articular Effusion
Time Frame: 5 weeks after surgery

Intra-articular effusion was assessed with the patient in a supine position and the knee in extension. The patient was required to remain relaxed to allow accurate assessment of post-surgical joint effusion using the "Stroke test." During this test, the evaluator performed sweeping strokes with the hands from medial to lateral and vice versa, observing the behavior of the effusion and whether it returned to the medial side.

This test is graded on a 0-3 scale: 0 indicates no detectable effusion; 1 indicates a measurable fluid wave with a single maneuver; 2 indicates visible fluid with slight pressure; and 3 indicates a large effusion without the need for pressure.

This method is validated by the IKDC 2000 (International Knee Documentation Committee) and is widely used in research studies.

5 weeks after surgery
Knee Range of Motion
Time Frame: 5 weeks after surgery

Active and passive knee range of motion was measured using a universal manual goniometer, a highly validated tool commonly used in clinical physiotherapy practice.

The patient was positioned supine for accurate measurement. The greater trochanter was identified, and the patient was asked to actively flex the knee by sliding the heel along the table without using the hands.

The evaluator stabilized the operated limb with the caudal hand and placed the axis of the goniometer over the lateral femoral condyle. The proximal arm was aligned with the midline of the thigh toward the greater trochanter, and the distal arm with the midline of the leg toward the lateral malleolus.

For knee extension, the patient remained in a supine position with the heel, gastrocnemius, and hamstring musculature supported on the table. The patient was then asked to perform active extension, and the goniometer was positioned using the same anatomical landmarks to determine both passive and active extension.

5 weeks after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

December 2, 2025

First Submitted That Met QC Criteria

May 4, 2026

First Posted (Actual)

May 6, 2026

Study Record Updates

Last Update Posted (Actual)

May 6, 2026

Last Update Submitted That Met QC Criteria

May 4, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • CE102505

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anterior Cruciate Ligament Reconstruction Rehabilitation

Clinical Trials on Experimental Group

Subscribe